Follow
Ana Blasco
Ana Blasco
Servicio de Oncología Médica. Hospital General Universitario de Valencia. CIBERONC
Verified email at gva.es
Title
Cited by
Cited by
Year
Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective …
A Carmona-Bayonas, P Jiménez-Fonseca, J Virizuela Echaburu, ...
Journal of Clinical Oncology 33 (5), 465-471, 2015
1832015
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ...
Expert review of molecular diagnostics 17 (3), 209-215, 2017
1812017
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
C Camps, B Massuti, A Jimenez, I Maestu, RG Gómez, D Isla, ...
Annals of Oncology 17 (3), 467-472, 2006
1722006
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer
R Sirera, RM Bremnes, A Cabrera, E Jantus-Lewintre, E Sanmartín, ...
Journal of Thoracic Oncology 6 (2), 286-290, 2011
1072011
Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
L Puchades-Carrasco, E Jantus-Lewintre, C Pérez-Rambla, ...
Oncotarget 7 (11), 12904, 2016
992016
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Y Escobar, G Cajaraville, JA Virizuela, R Álvarez, A Muñoz, O Olariaga, ...
Supportive Care in Cancer 23, 2833-2840, 2015
982015
Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
A Herreros-Pomares, JD de-Maya-Girones, S Calabuig-Fariñas, R Lucas, ...
Cell death & disease 10 (9), 660, 2019
882019
Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
C Camps, R Sirera, R Bremnes, A Blasco, E Sancho, P Bayo, MJ Safont, ...
Lung cancer 50 (3), 339-346, 2005
812005
Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC
E Jantus-Lewintre, E Sanmartín, R Sirera, A Blasco, JJ Sanchez, M Tarón, ...
Lung Cancer 74 (2), 326-331, 2011
762011
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions
S Villatoro, C Mayo‐de‐las‐Casas, N Jordana‐Ariza, S Viteri‐Ramírez, ...
Molecular oncology 13 (12), 2633-2645, 2019
722019
The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients
C Camps, E Jantus-Lewintre, A Cabrera, A Blasco, E Sanmartín, ...
Lung Cancer 72 (3), 365-369, 2011
692011
SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016)
M Muñoz, A Santaballa, MA Seguí, C Beato, S De La Cruz, J Espinosa, ...
Clinical and Translational Oncology 18, 1229-1236, 2016
602016
Importance of quality of life in patients with non–small-cell lung cancer
C Camps, N del Pozo, A Blasco, P Blasco, R Sirera
Clinical lung cancer 10 (2), 83-90, 2009
602009
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC)(2019)
M Dómine, T Moran, D Isla, JL Martí, I Sullivan, M Provencio, ME Olmedo, ...
Clinical and Translational Oncology 22, 245-255, 2020
592020
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients
J Garde-Noguera, P Martin-Martorell, M De Julián, J Perez-Altozano, ...
Clinical and translational oncology 20, 1072-1079, 2018
582018
Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology
A Goday, I Barneto, JM García-Almeida, A Blasco, A Lecube, C Grávalos, ...
Clinical and Translational Oncology 17, 763-771, 2015
582015
Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
M Usó, E Jantus-Lewintre, RM Bremnes, S Calabuig, A Blasco, E Pastor, ...
Oncotarget 7 (33), 52849, 2016
422016
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer
J Zugazagoitia, M Biosca, J Oliveira, ME Olmedo, M Dómine, E Nadal, ...
European Respiratory Journal 51 (5), 2018
392018
A consensus statement on the gender perspective in lung cancer
D Isla, M Majem, N Viñolas, A Artal, A Blasco, E Felip, P Garrido, J Remón, ...
Clinical and Translational Oncology 19, 527-535, 2017
392017
Jacob's disease associated with temporomandibular joint dysfunction: a case report.
A Capote, FJ Rodríguez, A Blasco, MF Muñoz
Medicina oral, patologia oral y cirugia bucal 10 (3), 210-214, 2005
392005
The system can't perform the operation now. Try again later.
Articles 1–20